Beta RBD boost broadens antibody-mediated protection against SARS-CoV-2 variants in animal models

Beta RBD boost broadens antibody-mediated protection against SARS-CoV-2 variants in animal models

Summary: Severe acute respiratory syndrome-coronavirus 2 (SARS-CoV-2) variants of concern (VOCs) with resistance to neutralizing antibodies are threatening to undermine vaccine efficacy. Vaccination and infection have led to widespread humoral immunity against the pandemic founder (Wu-Hu-1). Against...

Full beskrivning

Bibliografiska uppgifter
Huvudupphovsmän: Daniel J. Sheward, Marco Mandolesi, Egon Urgard, Changil Kim, Leo Hanke, Laura Perez Vidakovics, Alec Pankow, Natalie L. Smith, Xaquin Castro Dopico, Gerald M. McInerney, Jonathan M. Coquet, Gunilla B. Karlsson Hedestam, Ben Murrell
Materialtyp: Artikel
Språk:English
Publicerad: Elsevier 2021-11-01
Serie:Cell Reports Medicine
Ämnen:
SARS-CoV-2
variants of concern
vaccines
original antigenic sin
heterotypic boost
passive immunization
Länkar:http://www.sciencedirect.com/science/article/pii/S2666379121003189

Internet

http://www.sciencedirect.com/science/article/pii/S2666379121003189

Liknande verk